Korro Bio, Inc. Common Stock

KRRONASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
9.76 USD
↘ 0.21 (2.11%)AT CLOSE (03:59 PM EDT)
9.77
↗ 0.01 (0.05%)
POST MARKET (AS OF 05:19 PM EDT)
Post Market
AS OF 05:19 PM EDT
9.77
↗ 0.01 (0.05%)
🟢Market: OPEN

Korro Bio, Inc. Common Stock (KRRO) is currently trading at $9.77. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, KRRO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 6, 2026.

Open?$10.20
High?$10.35
Low?$9.47
Prev. Close?$9.97
Volume?142.6K
Avg. Volume?163.8K
VWAP?$9.82
Rel. Volume?0.87x
Bid / Ask
Bid?$8.39 × 100
Ask?$11.15 × 100
Spread?$2.76
Midpoint?$9.77
Valuation & Ratios
Market Cap?146.8M
Shares Out?14.7M
Float?11.7M
Float %?79.4%
P/E Ratio?N/A
P/B Ratio?1.42
EPS?-$7.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
57
Market Cap
146.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.korrobio.com
Listed
2023-11-06
Address
60 FIRST STREET
CAMBRIDGE, MA 02141
Phone: 617-468-1999
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.57Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.27%High
Short Interest?1.6M
Days to Cover?11.9
Free Float11.7M
Avg Daily Volume130.3K
Settlement Date2026-09-15
Financial Health
Current Ratio?9.55Strong
Quick Ratio?9.55Strong
Cash Ratio?1.97Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
89
1.42CHEAP▾
P/S?
Peers
100
S&P
3
61.64HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
51.18HIGH▾
Returns & Efficiency
ROE?
S&P
3
-103.3%WEAK▾
ROA?
S&P
3
-65.3%WEAK▾
Cash Flow & Enterprise
FCF?$-68265000
Enterprise Value?$121.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist